Testing effectiveness (Phase 2)Study completedNCT02017444
What this trial is testing
Safety and Effectiveness of 11b-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) to Treat Idiopathic Intracranial Hypertension.
Who this might be right for
Idiopathic Intracranial Hypertension
University of Birmingham 31